Metastatic Breast Cancer
News
Pembrolizumab plus chemo shows benefits for PD-L1–rich triple-negative breast cancer
Patients with triple-negative breast cancers with PD-L1 combined positive score higher than 10 had better progression-free survival with...
News
LOTUS: Ipatasertib plus paclitaxel may prolong OS in TNBC
Ipatasertib provided a “clinically meaningful,” but not statistically significant, 9-month improvement in median overall survival.
News
Mammography cuts risk for fatal breast cancers: New data
A large study showed a survival benefit from mammography, but an expert questioned the study’s methodology.
News
Novel immune activator boosts immunotherapy benefit in TNBC
News
EMBRACA shows no overall survival benefit with talazoparib
Talazoparib did not confer an overall survival benefit over chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast...
News
Metastatic cancer linked to worse outcomes of COVID-19
Article
ESMO gets creative with guidelines for breast cancer care in the COVID-19 era
News
FDA OKs new drug for triple-negative breast cancer
Sacituzumab govitecan-hziy (Trodelvy) is now approved for adults with metastatic triple-negative breast cancer who received at least two prior...
News
FDA approves first new breast cancer drug with international group
News
Breast-conserving surgery deemed okay in high-risk hereditary breast cancers
The presence of a germline BRCA1/2 mutation shouldn’t preclude breast-conserving therapy as long as the patient is otherwise eligible, new...